|
|
|
Insider
Information: |
Venker Eric |
Relationship: |
|
City: |
London |
State: |
X0 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
468,197 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,850,521 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
468,197 |
|
|
Total
Value |
$4,850,521 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Roivant Sciences Ltd. |
ROIV |
|
2024-05-20 |
468,197 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
98 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-04-28 |
4 |
AS |
$8.47 |
$642,221 |
D/D |
(75,823) |
675,768 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-04-28 |
4 |
OE |
$3.85 |
$291,919 |
D/D |
75,823 |
751,591 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-01 |
4 |
AS |
$8.59 |
$525,321 |
D/D |
(61,155) |
675,768 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-01 |
4 |
OE |
$3.85 |
$235,447 |
D/D |
61,155 |
736,923 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-02 |
4 |
AS |
$8.29 |
$904,223 |
D/D |
(109,074) |
675,768 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-02 |
4 |
OE |
$3.85 |
$419,935 |
D/D |
109,074 |
784,842 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-03 |
4 |
AS |
$8.40 |
$997,584 |
D/D |
(118,760) |
675,768 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-03 |
4 |
OE |
$3.85 |
$457,226 |
D/D |
118,760 |
794,528 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-04 |
4 |
AS |
$8.30 |
$737,355 |
D/D |
(88,838) |
675,768 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-04 |
4 |
OE |
$3.85 |
$342,026 |
D/D |
88,838 |
764,606 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-08 |
4 |
OE |
$3.85 |
$235,643 |
D/D |
61,206 |
736,974 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-08 |
4 |
AS |
$8.93 |
$546,570 |
D/D |
(61,206) |
675,768 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-09 |
4 |
AS |
$9.23 |
$2,203,423 |
D/D |
(238,724) |
675,768 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-09 |
4 |
OE |
$3.85 |
$919,087 |
D/D |
238,724 |
914,492 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-23 |
4 |
AS |
$9.85 |
$4,088 |
D/D |
(415) |
675,768 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-23 |
4 |
OE |
$3.85 |
$1,598 |
D/D |
415 |
676,183 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-05-23 |
4 |
AS |
$9.58 |
$150,128 |
D/D |
(15,671) |
660,097 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-06-07 |
4 |
AS |
$9.85 |
$1,980 |
D/D |
(201) |
660,097 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-06-07 |
4 |
OE |
$3.85 |
$774 |
D/D |
201 |
660,298 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-06-09 |
4 |
AS |
$9.91 |
$2,966,895 |
D/D |
(299,384) |
660,097 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-06-09 |
4 |
OE |
$3.85 |
$1,152,628 |
D/D |
299,384 |
959,481 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-06-22 |
4 |
AS |
$10.01 |
$158,979 |
D/D |
(15,882) |
644,215 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-07-20 |
4 |
AS |
$11.31 |
$1,802,667 |
D/D |
(159,387) |
644,215 |
0 |
% |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-07-20 |
4 |
OE |
$3.85 |
$613,640 |
D/D |
159,387 |
803,602 |
0 |
- |
|
ROIV |
Roivant Sciences Ltd. |
President & COO |
|
2023-07-21 |
4 |
AS |
$11.13 |
$2,025,638 |
D/D |
(181,998) |
644,215 |
0 |
% |
|
98 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|